NCT03295734View on ClinicalTrials.gov

ACES - ACE Inhibitors Combined With Exercise for Seniors With Hypertension

PHASE2CompletedINTERVENTIONAL
Enrollment

223

Participants

Timeline

Start Date

May 29, 2018

Primary Completion Date

September 19, 2024

Study Completion Date

September 19, 2024

Conditions
HypertensionAgingSedentary Lifestyle
Interventions
BEHAVIORAL

Aerobic exercise

Twice weekly centered based aerobic exercise + 3/week home-based walking

DRUG

Perindopril

4 mg qd titrated to 8 mg qd perindopril

DRUG

Losartan

50 mg qd titrated to 100 qd losartan

DRUG

HCTZ

12.5 mg qd titrated to 25 qd HCTZ

Trial Locations (2)

32804

Translational Research Institute, Orlando

35205

UAB Center for Exercise Medicine, Birmingham

All Listed Sponsors
collaborator

University of Colorado, Denver

OTHER

collaborator

AdventHealth Translational Research Institute

OTHER

lead

University of Alabama at Birmingham

OTHER

NCT03295734 - ACES - ACE Inhibitors Combined With Exercise for Seniors With Hypertension | Biotech Hunter | Biotech Hunter